Article
MET Exon 14 Skipping and Novel Actionable Variants: Diagnostic and Therapeutic Implications in Latin American Non-Small-Cell Lung Cancer Patients.
International journal of molecular sciences - 22 Dec 2024
Rivas Solange, Sepúlveda Romina V, Tapia Ignacio, Estay Catalina, Soto Vicente, Blanco Alejandro, González Evelin, Armisen Ricardo
Abstract excerpt
Targeted therapy indications for actionable variants in non-small-cell lung cancer (NSCLC) have primarily been studied in Caucasian populations, with limited data on Latin American patients. This study utilized a 52-genes next-generation sequencing (NGS) panel to analyze 1560 tumor biopsies from NSCLC patients in Chile, Brazil, and Peru. The RNA sequencing reads and DNA coverage were correlated to improve the...
Topics
Join the communities discussing this publication.
